We are live on ! Find out more
CM

CS McKee Portfolio holdings

AUM $1.09B
1-Year Est. Return 31.33%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+31.33%
3 Year Est. Return
+47.55%
5 Year Est. Return
+66.61%
10 Year Est. Return
–
AUM
$1.09B
AUM Growth
-$12.3M
Cap. Flow
-$107M
Cap. Flow %
-9.83%
Top 10 Hldgs %
32.88%
Holding
102
New
2
Increased
26
Reduced
65
Closed
2

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$9.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$8.6M
3
OXY icon
Occidental Petroleum
OXY
+$2.05M
4
GILD icon
Gilead Sciences
GILD
+$1.39M
5
FCX icon
Freeport-McMoran
FCX
+$1.19M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$16M
2
KMT icon
Kennametal
KMT
+$8.75M
3
AAPL icon
Apple
AAPL
+$7.48M
4
MSFT icon
Microsoft
MSFT
+$5.74M
5
JPM icon
JPMorgan Chase
JPM
+$5.58M

Sector Composition

Rank Sector Weight
1 Technology 20.94%
2 Financials 16.41%
3 Industrials 13.05%
4 Healthcare 12.6%
5 Communication Services 12.22%

No holdings matched the selected filter criteria.

1 2 3 4 5

Similar funds

TRAM
Tuscan Ridge Asset Management Chicago, Illinois $984M AUM 25.8% 1-Year Est. Return
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
CONA
Capital One National Association New York $756M AUM
CBU
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SC
Selz Capital New York $570M AUM 35.56% 1-Year Est. Return
KGACF
Kopernik Global All-Cap Fund Tampa, Florida $558M AUM
BPWA
Beacon Pointe Wealth Advisors Newport Beach, California $543M AUM 23.61% 1-Year Est. Return

CS McKee's Q4 2019 Portfolio in Review

As of Q4 2019, CS McKee held 102 positions worth $1.09B, down 1.1% from $1.11B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

CS McKee withdrew a net $107M in Q4 2019, closing 2 positions and reducing 65 holdings. Its most notable exit was Celgene Corp, an estimated $16M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

Against the trend, CS McKee opened a new position in Bristol-Myers Squibb worth $9.63M.

  • CS McKee's largest Q4 2019 buy was Bristol-Myers Squibb: 150,100 shares worth $9.63M.
  • CS McKee added most to RTX Corp in Q4 2019, an estimated $9.5M increase.
  • CS McKee's biggest Q4 2019 reduction was Apple, cutting an estimated $7.48M.
  • CS McKee fully exited Celgene Corp in Q4 2019, selling an estimated $16M.
  • CS McKee's ten largest holdings make up 33% of its $1.09B portfolio in Q4 2019.
  • CS McKee opened 2 new positions and closed 2 in Q4 2019.
  • CS McKee's portfolio value fell 1.1% quarter-over-quarter to $1.09B.

Based on CS McKee's 13F filing for Q4 2019, filed 14 Feb 2020.